Company lists · Data refreshed September 2026

Top 19 Immunotherapy venture capital companies based in New York, United States

RevenueBase identified 29 immunotherapy venture capital companies headquartered in New York, United States as of September 2026 and tracks 464 professional contacts across them, including 212 with verified work emails. Cambridge is the largest hub.

This list covers immunotherapy venture capital companies headquartered in New York, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row Match evidence on every row Refreshed Sep 3, 2026 86% judged on-target in blind review
29Companies
464Contacts tracked
212Verified emails
Unlock all 29 companies Free signup · no credit card · 500 free credits

The 19 largest immunotherapy venture capital companies based in New York, United States

Ranked by team size
Top 19 of 29 immunotherapy venture capital companies based in New York, United States, ranked by team size, largest first. Data refreshed Sep 3, 2026. Evidence rates how directly each company's own description names immunotherapy venture capital companies: strong (names it), partial (names part of it), indirect (matched on its full profile rather than the summary shown). Click a count to unlock that company's people.
#CompanyHeadquartersEmployeesContacts
1New York, NY, United StatesHQ checked Sep 3, 202611-50132

“The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration…”

Source: company website · checked Sep 3, 2026
2
IGIIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 202651-200129

“IGI, Inc.”

Source: company website · checked Sep 3, 2026
3
In8bioIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 202611-5029

“IN8bio, Inc.”

Source: company website · checked Sep 3, 2026
4
Waypoint BIOIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 202611-5020

“Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.”

Source: company website · checked Sep 3, 2026
5
BeyondspringIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 202611-5020

“BeyondSpring Pharmaceuticals is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes.”

Source: company website · checked Sep 3, 2026
6
Aisling CapitalPartial evidence
New York, NY, United StatesHQ checked Sep 3, 202611-5017

“Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology.”

Source: company website · checked Sep 3, 2026
7
Aethon TherapeuticsPartial evidence
New York, NY, United StatesHQ checked Sep 3, 202611-5014

“Aethon takes a novel approach to fighting cancer, creating custom antibody therapeutics that unite immunotherapy and targeted therapy.”

Source: company website · checked Sep 3, 2026
8
Sanavia Oncology INCPartial evidence
New York, NY, United StatesHQ checked Sep 3, 202611-5013

“We are a New York City-based biotech focused on developing effective new immunotherapies for the 80% of cancer patients today’s treatments can’t reach.”

Source: company website · checked Sep 3, 2026
9
Indaptus Therapeutics, INCIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 20261-107

“The Indaptus Goal is Simple: to Cure Disease With the ability to harness both the body’s innate and adaptive immune responses, we believe we are uniquely positioned to…”

Source: company website · checked Sep 3, 2026
10
Frezent BiologicalIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 20261-107

“Despite advances in cancer therapy, recurrence remains a major unmet need and a leading cause of cancer-related mortality.”

Source: company website · checked Sep 3, 2026
11
Medicovestor, INCIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 20261-106

“Unleashing the Power of Antibodies to Fight Cancer: We aim to unlock the full potential of antibodies and their applications, enabling breakthrough precision medicines for a wide…”

Source: company website · checked Sep 3, 2026
12
Nodenza Venture PartnersStrong evidence
New York, United StatesHQ checked Sep 3, 20261-105

“Nodenza Venture Partners is a global Biotech and Medtech Venture Capital Fund that invests in early-stage & pre-commercial companies.”

Source: company website · checked Sep 3, 2026
13
TFC TherapeuticsIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 20261-105

“TFC Therapeutics is developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis.”

Source: company website · checked Sep 3, 2026
14
Dracen Pharmaceuticals, INCIndirect evidence
New York, United StatesHQ checked Sep 3, 20261-105

“Private biotech company leveraging immuno-metabolism to create a potential new treatment paradigm with broad application for many cancer types.”

Source: company website · checked Sep 3, 2026
15
Novita PharmaceuticalsIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 202611-504

“Novita Pharmaceuticals, Inc.”

Source: company website · checked Sep 3, 2026
16
Egret TherapeuticsIndirect evidence
New York, United StatesHQ checked Sep 3, 20261-104

“Egret Therapeutics is a clinical-stage biotechnology company developing a novel therapy to reprogram the immune response that drives secondary inflammation - the hidden cause of…”

Source: company website · checked Sep 3, 2026
17
ENB TherapeuticsIndirect evidence
New York, NY, United StatesHQ checked Sep 3, 20261-104

“ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients.”

Source: company website · checked Sep 3, 2026
18
Mablytics, INCPartial evidence
New York, NY, United StatesHQ checked Sep 3, 20261-102

“Mablytics is a preclinical-stage biotechnology company developing immunotherapies that are precisely delivered by means of a novel target.”

Source: company website · checked Sep 3, 2026
19New York, NY, United StatesHQ checked Sep 3, 20261-102

“Alphageneron Pharmaceuticals Inc,(“Alphageneron”) is a private clinical stage biopharmaceutical company advancing Natural Killer Cell (“NK Cell”) immunotherapies for hematologic…”

Source: company website · checked Sep 3, 2026

Showing 19 of 29 immunotherapy venture capital companies based in New York, United States

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 212 reachable decision-makers.

Free signup · no credit card

See all 29 companies

Immunotherapy venture capital companies based in New York, United States at a glance

As of Sep 3, 2026
1-10Median size (employees)
CambridgeLargest hub · 50 HQs
Contacts with mobile numbers
Sep 3, 2026Data refreshed

Companies by employee count

1-10
20
11-50
8
51-200
1

Email recency for this list is measured across the whole United States list rather than this city, so it is reported there. Company counts and contact totals on this page are exact for New York, over 29 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in New York, United States whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
What we exclude
Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside New York are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 212 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

How many immunotherapy venture capital companies are there based in New York, United States?

RevenueBase identified 29 immunotherapy venture capital companies headquartered in New York, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Cancer Research Institute CRI, headquartered in New York, tops this list with the largest team on record.

Which city has the most immunotherapy venture capital companies?

Cambridge leads with 50 headquartered companies, followed by San Diego (49) and Boston (39).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 212 verified decision-maker contacts tracked across these 29 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.

Ready to reach these companies? Verified emails and direct dials for all 29 immunotherapy venture capital companies based in New York, United States. Start with a free account, no credit card.

Get the full list

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.